- Home
- BEAT vs VTGN Comparison
BEAT vs VTGN Comparison
Compare BEAT & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- VTGN
- Stock Information
- Founded
- BEAT 2015
- VTGN 1998
- Country
- BEAT United States
- VTGN United States
- Employees
- BEAT N/A
- VTGN N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- BEAT Technology
- VTGN Health Care
- Exchange
- BEAT Nasdaq
- VTGN Nasdaq
- Market Cap
- BEAT 74.1M
- VTGN 81.3M
- IPO Year
- BEAT 2021
- VTGN N/A
- Fundamental
- Price
- BEAT $2.14
- VTGN $2.92
- Analyst Decision
- BEAT Buy
- VTGN
- Analyst Count
- BEAT 1
- VTGN 0
- Target Price
- BEAT $8.00
- VTGN N/A
- AVG Volume (30 Days)
- BEAT 117.1K
- VTGN 401.9K
- Earning Date
- BEAT 11-07-2024
- VTGN 02-11-2025
- Dividend Yield
- BEAT N/A
- VTGN N/A
- EPS Growth
- BEAT N/A
- VTGN N/A
- EPS
- BEAT N/A
- VTGN N/A
- Revenue
- BEAT N/A
- VTGN $876,000.00
- Revenue This Year
- BEAT N/A
- VTGN N/A
- Revenue Next Year
- BEAT N/A
- VTGN N/A
- P/E Ratio
- BEAT N/A
- VTGN N/A
- Revenue Growth
- BEAT N/A
- VTGN 8.08
- 52 Week Low
- BEAT $1.35
- VTGN $2.22
- 52 Week High
- BEAT $3.48
- VTGN $5.74
- Technical
- Relative Strength Index (RSI)
- BEAT 39.59
- VTGN 53.24
- Support Level
- BEAT $2.00
- VTGN $2.40
- Resistance Level
- BEAT $2.30
- VTGN $3.40
- Average True Range (ATR)
- BEAT 0.16
- VTGN 0.21
- MACD
- BEAT -0.00
- VTGN -0.00
- Stochastic Oscillator
- BEAT 35.00
- VTGN 47.83
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.